STAAR Surgical Co Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss
STAAR Surgical Co (STAA) reported Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss of $0 for the 3-month period ending 2024-06-28, per its 10-Q filed 2024-08-07.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments · last filed 2024-08-07
- STAAR Surgical Co marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2024-06-28 was $0.00.
- STAAR Surgical Co marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2024-03-29 was $0.00.
- STAAR Surgical Co marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2023-12-29 was $0.00.
- STAAR Surgical Co marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for the quarter ending 2023-09-29 was $0.00.
- STAAR Surgical Co marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2023 was $0.00.
- STAAR Surgical Co marketable securities, realized gain (loss), excluding other-than-temporary impairment loss for fiscal 2022 was $0.00.
| Period end | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 3 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 6 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 9 month | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss 12 month |
|---|---|---|---|---|
| 2024-06-28 | $0.00 10-Q · filed 2024-08-07 | $0.00 10-Q · filed 2024-08-07 | $0.00 derived: sum of 3 quarters · filed 2024-08-07 | $0.00 derived: sum of 4 quarters · filed 2024-08-07 |
| 2024-03-29 | $0.00 10-Q · filed 2024-05-07 | $0.00 derived: sum of 2 quarters · filed 2024-05-07 | $0.00 derived: sum of 3 quarters · filed 2024-05-07 | $0.00 derived: sum of 4 quarters · filed 2024-05-07 |
| 2023-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 |
| 2023-09-29 | $0.00 10-Q · filed 2023-11-06 | $0.00 derived: sum of 2 quarters · filed 2023-11-06 | $0.00 10-Q · filed 2023-11-06 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-06-30 | $0.00 10-Q · filed 2023-08-02 | $0.00 10-Q · filed 2023-08-02 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | $0.00 derived: sum of 4 quarters · filed 2024-02-27 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-03 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 derived: sum of 3 quarters · filed 2024-02-27 | |
| 2022-12-30 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $0.00 derived: sum of 2 quarters · filed 2024-02-27 | $0.00 10-K · filed 2024-02-27 | |
| 2022-09-30 | $0.00 10-Q · filed 2022-11-02 | $0.00 10-Q · filed 2022-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| National Vision Holdings, Inc. (EYE) | United States | $1.297B | |
| RxSight, Inc. (RXST) | United States | $0.197B | |
| Innovative Eyewear Inc (LUCY) | United States | $0.008B | |
| Warby Parker Inc. (WRBY) | United States | $2.970B | |
| Bausch & Lomb Corp (BLCO) | Canada | $6.008B | -34.58 |
| COOPER COMPANIES, INC. (COO) | United States | $10.533B | 24.09 |